Accessibility Statement

Atravix® is committed to making its website and platform accessible to all users, including those with disabilities. We aim to meet the Web Content Accessibility Guidelines (WCAG) 2.2 Level AA standard.

We recognise that accessibility is an ongoing effort and we are committed to continually improving the accessibility of our services.

• Designing with sufficient colour contrast to aid readability
• Ensuring keyboard navigation is supported throughout the platform
• Providing appropriate focus states and skip navigation links
• Using semantic HTML to support screen readers and assistive technologies
• Testing with assistive technologies where possible
• Reviewing accessibility as part of ongoing development
• Aiming for WCAG 2.2 Level AA compliance across all pages

We are aware that some parts of the website and platform may not yet fully meet WCAG 2.2 AA standards. We are actively working to identify and address any accessibility gaps. If you encounter a specific accessibility issue, please contact us and we will prioritise a resolution.

If you experience an accessibility problem on the Atravix® website or platform, we would like to hear about it. Please contact us with:

• A description of the accessibility problem you encountered
• The page or section of the platform where the issue occurred
• The device, browser and assistive technology you were using (if known)
• Your contact details so we can follow up

Contact us at: info@atravix.com

We aim to acknowledge accessibility reports within 5 working days and to provide a substantive response within 20 working days.

If you are not satisfied with our response to an accessibility report, you may contact the Equality Advisory and Support Service (EASS) at equalityadvisoryservice.com.

Public sector bodies in the UK also have obligations under the Public Sector Bodies (Websites and Mobile Applications) Accessibility Regulations 2018. If applicable to Atravix®, we will publish a separate accessibility statement in accordance with those regulations.

Sach Capital Limited (trading as Atravix®) · 124 City Road, London, EC1V 2NX, England · info@atravix.com